Evercore ISI Issues Pessimistic Forecast for Clorox (NYSE:CLX) Stock Price

Clorox (NYSE:CLX) had its target price cut by equities research analysts at Evercore ISI from $132.00 to $115.00 in a research note issued to investors on Wednesday, Marketbeat Ratings reports. The firm presently has an “underperform” rating on the stock. Evercore ISI’s target price would indicate a potential downside of 2.21% from the stock’s previous close.

Other analysts have also recently issued research reports about the stock. Zacks Research raised shares of Clorox from a “strong sell” rating to a “hold” rating in a report on Wednesday, November 26th. The Goldman Sachs Group dropped their price target on Clorox from $110.00 to $94.00 and set a “sell” rating on the stock in a research report on Wednesday, January 7th. Citigroup upped their price objective on shares of Clorox from $109.00 to $115.00 and gave the stock a “neutral” rating in a research report on Wednesday. Wall Street Zen downgraded Clorox from a “hold” rating to a “sell” rating in a research note on Saturday, January 24th. Finally, Morgan Stanley cut their price target on shares of Clorox from $137.00 to $125.00 and set an “equal weight” rating for the company in a report on Tuesday, November 4th. One research analyst has rated the stock with a Buy rating, ten have assigned a Hold rating and five have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and a consensus price target of $117.93.

Clorox Stock Performance

Shares of CLX opened at $117.59 on Wednesday. Clorox has a 1 year low of $96.66 and a 1 year high of $159.04. The stock has a market capitalization of $14.22 billion, a PE ratio of 19.21, a PEG ratio of 0.57 and a beta of 0.59. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.50 and a current ratio of 0.74. The stock has a 50-day simple moving average of $105.58 and a 200-day simple moving average of $114.01.

Clorox (NYSE:CLX) last issued its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing the consensus estimate of $1.43 by ($0.04). Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period last year, the business earned $1.55 EPS. The firm’s revenue was down .8% compared to the same quarter last year. On average, analysts predict that Clorox will post 7.15 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Pierre R. Breber acquired 4,000 shares of the company’s stock in a transaction dated Friday, November 21st. The stock was acquired at an average cost of $104.13 per share, for a total transaction of $416,520.00. Following the acquisition, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. This represents a 44.44% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at this link. 0.63% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Clorox

Institutional investors have recently added to or reduced their stakes in the company. Aegis Wealth Management Inc. acquired a new position in shares of Clorox in the 4th quarter valued at about $820,000. North Dakota State Investment Board purchased a new position in Clorox in the fourth quarter valued at approximately $428,000. Canada Post Corp Registered Pension Plan lifted its position in Clorox by 31.9% during the fourth quarter. Canada Post Corp Registered Pension Plan now owns 2,690 shares of the company’s stock valued at $271,000 after buying an additional 650 shares in the last quarter. Everstar Asset Management LLC grew its stake in Clorox by 259.3% during the fourth quarter. Everstar Asset Management LLC now owns 24,183 shares of the company’s stock worth $2,438,000 after buying an additional 17,452 shares during the period. Finally, 1620 Investment Advisors Inc. acquired a new stake in shares of Clorox in the fourth quarter worth $159,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Key Stories Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Morgan Stanley raised its price target to $136 (equal-weight), signaling meaningful upside versus the current level and providing buy-side support. Article Title
• Positive Sentiment: Jefferies kept a Buy rating and a high target (~$151), reinforcing a bullish view on longer-term recovery and giving investors a favorable risk/reward case. Article Title
• Neutral Sentiment: Clorox reiterated its 2026 outlook despite mixed Q2 results, which limits downside if management delivers on guidance and execution. Article Title
• Neutral Sentiment: Clorox will present at the CAGNY conference (Feb. 19), offering investors a near-term opportunity for management to outline strategy and provide more color on ERP integration and potential M&A (GOJO). Article Title
• Negative Sentiment: Q2 results were mixed: adjusted EPS missed estimates ($1.39 vs. $1.43), organic sales fell year-over-year, and margin pressure from higher costs and ERP-related expenses was highlighted — primary near-term negative catalyst. Article Title
• Negative Sentiment: Evercore cut its target sharply to $115 and kept an Underperform rating, increasing sell-side pressure and signalling concerns about near-term profitability. Article Title
• Negative Sentiment: Deutsche Bank trimmed its target to $112 (hold), and TD Cowen’s $111 target (hold) also implies downside — several shops are skeptical on margins and the ERP/integration timeline. Article Title Article Title
• Negative Sentiment: BofA flagged margin uncertainty after the Q2 miss even while nudging its target to $112 — a reminder margins and execution (inventory reset, ERP) are the biggest risks near term. Article Title

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.